The HER/ErbB family of receptors including EGFR (HER1/ErbB1), HER2 (ErbB2), HER3 (ErbB3) and HER4 (ErbB4) plays a critical role in tumorigenesis including thyroid cancer [18–20]. Here, ERBB2 is linked to thyroid gland carcinoma.